Peter Foley, BMedSc, MB BS, MD, FACD

Skin and Cancer Foundation

Level 1, 80 Drummond Street
Carlton, Victoria, Australia
3053
03 9623 9400

 

Specialty: Dermatology

 
Dr. Peter Foley, Dermatologist Specialist in Psoriasis

Research Interests: Acne, Actinic Keratosis, Alopecia, Atopic Dermatitis (Eczema), Basal Cell Carcinoma, Bowen's Disease, Cutaneous T-cell Lymphoma, Dermatitis, Mycosis Fungoides, Onychomycosis, Psoriasis, Rosacea, Seborrhoeic Dermatitis, Tinea Corprois, Tinea Pedis, Tinea Versicolor, Wrinkles

Associate Professor Peter Foley has been practicing dermatology in Victoria, Australia for over 10 years.  Dr. Foley joined the Skin and Cancer Foundation in 2005 where Dr. Foley and his colleagues (over 50 dermatologists and specialists) host clinics for psoriasis, atopic dermatitis (eczema), vitiligo, organ transplant recipients, melanoma, and non-melanoma skin cancer, including actinic keratosis. 

The Skin and Cancer Foundation has been an investigative site for over fifty clinical trials, most with Associate Professor Peter Foley as Principal Investigator.  Dr. Foley has conducted clinical trials for many dermatologic conditions and diseases, including psoriasis, acne, psoriatic arthritis, and actinic keratosis.

Dr. Foley is a member of numerous associations including the American Academy of Dermatology, Victorian Cooperative Oncology Group, Australasian College of Dermatologists, Cancer Council Australia, and Australasian College of Dermatologists.

Dr. Peter Foley’s current positions include Steering Committee Member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), and Associate Professor of Dermatology at the University of Melbourne.  Dr. Foley is also a Visiting Dermatologist at St Vincent’s Hospital Melbourne and at the Skin and Cancer Foundation.

 

Click to view Dr. Peter Foley's Publications

Norris D, Photiou L, Tacey M, Dolianitis C, Varigos G, Foley P, Baker C. Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population. J Dermatolog Treat 2017 Dec; 28(8): 731-6. Epub 2017 Jun 23. PMID: 28489479 / doi: 10.1080/09546634.2017.1329501

Gordon KB, Blauvelt A, Foley P, Song M, Wasfi Y, Randazzo B, Shen YK, You Y, Griffiths CEM. Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the Phase 3 VOYAGE 1 and VOYAGE 2 studies. Br J Dermatol 2017 Sep 22 [Epub ahead of print]. PMID: 28940259 / doi: 10.1111/bjd.16008

Rademaker M, Gupta M, Andrews M, Armour K, Baker C, Foley P, Gebauer K, George J, Rubel D, Sullivan J. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting. Australas J Dermatol 2017 Aug; 58(3): 166-70. Epub 2016 Jul 12. PMID: 27402434 / doi: 10.1111/ajd.12521

Papp K, Bachelez H, Costanzo A, Foley P, Gooderham M, Kaur P, Philipp S, Spelman L, Zhang N, Strober B. Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomised, double-blind, 52-week, phase 3 study in moderate-to-severe plaque psoriasis patients. Br J Dermatol 2017 Jul 28 [Epub ahead of print]. PMID: 28755394 / doi: 10.1111/bjd.15857

Cohen AD, Wu JJ, Puig L, Chimenti S, Vender R, Rajagopalan M, Romiti R, de la Cruz C, Skov L, Zachariae C, Young HS, Foley P, van der Walt JM, Naldi L, Blauvelt A. Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice. Br J Dermatol 2017 Jun 24 [Epub ahead of print]. PMID: 28646580 / doi: 10.1111/bjd.15756

Norris D, Photiou L, Tacey M, Dolianitis C, Varigos G, Foley P, Baker C. Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population. J Dermatolog Treat 2017 Jun 23: 1-6 [Epub ahead of print]. PMID: 28489479 / doi: 10.1080/09546634.2017.1329501

Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, Pujol RM, Szepietowski JC, Ettler K, Kemény L, Zhu X, Akinlade B, Hultsch T, Mastey V, Gadkari A, Eckert L, Amin N, Graham NMH, Pirozzi G, Stahl N, Yancopoulos GD, Shumel B. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet 2017 Jun 10; 389(10086): 2287-303. Epub 2017 May 4. PMID: 28478972 / doi: 10.1016/S0140-6736(17)31191-1

Papp K, Bachelez H, Costanzo A, Foley P, Gooderham M, Kaur P, Narbutt J, Philipp S, Spelman L, Weglowska J, Zhang N, Strober B. Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study. J Am Acad Dermatol 2017 Jun; 76(6): 1093-1102. Epub 2017 Mar 11. PMID: 28291552 / doi: 10.1016/j.jaad.2016.12.014

Rademaker M, Agnew K, Andrews M, Armour K, Baker C, Foley P, Frew J, Gebauer K, Gupta M, Kennedy D, Marshman G, Sullivan J. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol 2017 May 23 [Epub ahead of print]. PMID: 28543445 / doi: 10.1111/ajd.12641

Calzavara-Pinton P, Hædersdal M, Barber K, Basset-Seguin N, Del Pino Flores ME, Foley P, Galimberti G, Gerritsen R, Gilarbete Y, Ibbotson S, Peris K, Sapra S, Sotiriou E, Torezan L, Ulrich C, Guillemot J, Hendrich J, Szeimies RM. Structured expert consensus on actinic keratosis: Treatment algorithm focusing on daylight PDT. Cutan Med Surg 2017 Apr 1 [Epub ahead of print]. PMID: 28406719 / doi: 10.1177/1203475417702994

Reich K, Armstrong AW, Foley P, Song M, Wasfi Y, Randazzo B, Li S, Shen YK, Gordon KB. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial. J Am Acad Dermatol 2017 Mar; 76(3): 418-31. Epub 2017 Jan 2. PMID: 28057361 / doi: 10.1016/j.jaad.2016.11.042

van de Kerkhof P, Guenther L, Gottlieb AB, Sebastian M, Wu JJ, Foley P, Morita A, Goldblum O, Zhang L, Erickson J, Ball S, Rich P. Ixekizumab treatment improves fingernail psoriasis in patients with moderate-to-severe psoriasis: results from the randomized, controlled and open-label phases of UNCOVER-3. J Eur Acad Dermatol Venereol 2017 Mar; 31(3): 477-82. Epub 2016 Dec 2. PMID: 27910156 / doi: 10.1111/jdv.14033

Gupta M, Rademaker M, Sullivan JR, Foley P. A decade of Australian methotrexate dosing errors. Med J Aust 2016 Nov 21;205(10):485. PMID: 27852189

Thaçi D, Kimball A, Foley P, Poulin Y, Levi E, Chen R, Feldman SR. Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials. J Eur Acad Dermatol Venereol 2017 Mar; 31(3): 498-506. Epub 2016 Oct 10. PMID: 27538241 / doi: 10.1111/jdv.13918

Nguyen R, Braue A, Baker C, Foley P. Five-year experience with infliximab: Follow up of the product familiarisation program. Australas J Dermatol 2016 Nov; 57(4): 300-6. Epub 2015 Sep 16. PMID: 26374405 / doi: 10.1111/ajd.12391

Foley P, Stockfleth E, Peris K, Basset-Seguin N, Cerio R, Antonio Sanches J, Guillen C, Farrington E, Lebwohl M. Adherence to topical therapies in actinic keratosis: A literature review. J Dermatolog Treat 2016 Nov; 27(6): 538-45. Epub 2016 May 10. PMID: 27161045 / doi: 10.1080/09546634.2016.1178372

See JA, Shumack S, Murrell DF, Rubel DM, Fernández-Peñas P, Salmon R, Hewitt D, Foley P, Spelman L. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australas J Dermatol 2016 Aug; 57(3): 167-74. Epub 2015 May 31. PMID: 26033230 / doi: 10.1111/ajd.12354

Rademaker M, Gupta M, Andrews M, Armour K, Baker C, Foley P, Gebauer K, George J, Rubel D, Sullivan J. The Australasian Psoriasis Collaboration view on methotrexate for psoriasis in the Australasian setting. Australas J Dermatol 2016 Jul 12. [Epub ahead of print] PMID: 27402434 / doi: 10.1111/ajd.12521

Sobell JM, Foley P, Toth D, Mrowietz U, Girolomoni G, Goncalves J, Day RM, Chen R, Yosipovitch G. Effects of apremilast on pruritus and skin discomfort/pain correlate with improvements in quality of life in patients with moderate to severe plaque psoriasis. Acta Derm Venereol 2016 Apr 12; 96(4): 514-20. PMID: 26837052 / doi: 10.2340/00015555-2360

Spelman L, Rubel D, Murrell DF, See JA, Hewitt D, Foley P, Salmon R, Kerob D, Pascual T, Shumack S, Fernandez-Penas P. Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study. Australas J Dermatol 2016 Feb; 57(1): 24-8. Epub 2015 Mar 31. PMID: 25827200 / doi: 10.1111/ajd.12295

Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, Gupta AK, Jacobs A, Kerl H, Lim HW, Martin G, Paquet M, Pariser DM, Rosumeck S, Röwert-Huber HJ, Sahota A, Sangueza OP, Shumack S, Sporbeck B, Swanson NA, Torezan L, Nast A.  Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version.  J Eur Acad Dermatol Venereol 2015 Nov; 29(11): 2069-79. Epub 2015 Sep 14. PMID: 26370093 / doi: 10.1111/jdv.13180

Nguyen R, Braue A, Baker C, Foley P. Five-year experience with infliximab: Follow up of the product familiarisation program. Australas J Dermatol 2015 Sep 16. [Epub ahead of print]. PMID: 26374405 / doi: 10.1111/ajd.12391

Ferguson JS, Hannam S, Toholka R, Chong AH, Magee J, Foley P. Hair loss and Hedgehog inhibitors: a class effect? Br J Dermatol 2015 Jul; 173(1): 262-4. Epub 2015 May 12. PMID: 25523648 / doi: 10.1111/bjd.13619

See JA, Shumack S, Murrell DF, Rubel DM, Fernández-Peñas P, Salmon R, Hewitt D, Foley P, Spelman L. Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia. Australas J Dermatol 2015 May 31. [Epub ahead of print]. PMID: 26033230 / doi: 10.1111/ajd.12354

Stockfleth E, Peris K, Guillen C, Cerio R, Basset-Seguin N, Foley P, Sanches J, Culshaw A, Erntoft S, Lebwohl M. A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis. Int J Dermatol 2015 May; 54(5): 509-15. Epub 2015 Apr 10. PMID: 25865875 / doi: 10.1111/ijd.12840

Bissonnette R, Iversen L, Sofen H, Griffiths CE, Foley P, Romiti R, Bachinsky M, Rottinghaus ST, Tan H, Proulx J, Valdez H, Gupta P, Mallbris L, Wolk R. Tofacitinib withdrawal and re-treatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial. Br J Dermatol 2015; 172(5): 1395-406. Epub 2015 Apr 2. PMID: 25418186 / doi: 10.1111/bjd.13551

Foley P. Current landscape for treatment of advanced basal cell carcinoma. Australas J Dermatol 2015 Mar; 56 Suppl S1: 1-7. PMID: 25715811 / doi: 10.1111/ajd.12319

Stockfleth E, Peris K, Guillen C, Cerio R, Basset-Sequin N, Foley P, Sanches J, Culshaw A, Erntoft S, Lebwohl M. Physician perceptions and experience of current treatment in actinic keratosis. J Eur Acad Dermatol Venereol 2015 Feb; 29(2): 298-306. Epub 2014 Jul 27. PMID: 25065394 / doi: 10.1111/jdv.12530

Kelly JB 3rd, Foley P, Strober BE. Current and future oral systemic therapies for psoriasis. Dermatol Clin 2015 Jan; 33(1): 91-109. PMID: 25412786 / doi: 10.1016/j.det.2014.09.008

Rubel DM, Spelman L, Murrell DF, See JA, Hewitt D, Foley P, Bosc C, Kerob D, Kerrouche N, Wulf HC, Shumack S. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol 2014 Nov; 171(5): 1164-71. Epub 2014 Oct 20. PMID: 24861492 / doi: 10.1111/bjd.13138

Tan E, Baker C, Foley P. Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis. Australas J Dermatol 2013 Nov; 54(4): 259-63. PMID: 24164178 / doi: 10.1111/ajd.12044

Mahar P, Baker C, Mar A, Foley P. Protecting the role of clinical photography in dermatology. Australas J Dermatol 2013 Aug; 54(3): 238-9. PMID: 23905979 / doi: 10.1111/ajd.12089

Baker C, Mack A, Cooper A, Fisher G, Shumack S, Sidhu S, Soyer P, Wu J, Chan J, Nash P, Rawlin M, Radulski B, Foley P. Treatment goals for moderate to severe psoriasis: an Australian consensus. Australas J Dermatol 2013 May; 54(2): 148-54. Epub 2013 Jan 18. PMID: 23330815 / doi: 10.1111/ajd.12014

Baker CS, Foley PA, Braue A. Psoriasis uncovered--measuring burden of disease impact in a survey of Australians with psoriasis. Australas J Dermatol 2013 Feb; 54 Suppl 1: 1-6. PMID: 23379483 / doi: 10.1111/ajd.12010

Mahar PD, Foley PA, Sheed-Finck A, Baker CS. Legal considerations of consent and privacy in the context of clinical photography in Australian medical practice. Med J Aust 2013 Jan 21; 198(1): 48-9. PMID: 23330771

Tan S, Foley PA. Emerging therapies in psoriasis. Medicine Today 2012 Oct; 13(10): 70-75.

Papp KA, Reid C, Foley P, Sinclair R, Salinger DH, Williams G, Dong H, Krueger JG, Russell CB, Martin DA. Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: Results from a phase I, randomized, placebo-controlled trial. J Invest Dermatol 2012 Oct; 132(10): 2466-9. Epub 2012 May 24. PMID: 22622425 / doi: 10.1038/jid.2012.163

Marcella S, Welsh B, Foley P. Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis. Australas J Dermatol 2011 Aug; 52(3): e8-11. Epub 2010 Jun 23. PMID: 21834808 / doi: 10.1111/j.1440-0960.2010.00660.x

Ng J, Foley PA. Treatment of actinic keratoses – be sure first. Medicine Today 2011 Jan; 12(1): 40-45.

Foley PA, Quirk C, Sullivan JR, Dolianitis C, Hack SP, Thirunavukkarasu K, Cooper AJ.  Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.  J Eur Acad Dermatol Venereol 2010 Oct; 24(10): 1135-43. PMID: 20337816 / doi: 10.1111/j.1468-3083.2010.03613.x

Lasocki A, Sinclair R, Foley P, Saunders H.  Hidradenitis suppurativa responding to treatment with infliximab.  Australas J Dermatol 2010 Aug; 51(3): 186-90. PMID: 20695857 / doi: 10.1111/j.1440-0960.2010.00623.x

Bajel A, Yin Lin M, Hill PA, Goodman D, McCormack C, Foley P, Davison J, Hönemann D, Kenealy M, Lade S, Ryan G, Prince HM. IgA nephropathy associated with cutaneous T cell lymphoma. Leuk Lymphoma 2009 Dec; 50(12): 2083-2085. PMID: 19863174

Foley P, Freeman M, Gebauer K, Murrell D, Shumack S, Tyson C, Varigos G. Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program. Int J Dermatol 2009 Dec; 48(12): 1376-1384. PMID: 19930495

Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt MT, Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S, Gibson LE, Tope WD. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol 2009 Nov; 48(11): 1236-1245. PMID: 20064185

Sinclair C, Foley P. Skin cancer prevention in Australia. Br J Dermatol 2009 Nov; 161(Suppl 3): 116-123. PMID: 19775367

Kieu V, O’Brien T, Yap LM, Baker C, Foley P, Mason G, Prince HM, McCormack C. Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab. Australas J Dermatol 2009 Aug; 50(3): 202-206. PMID: 19659984

Sladden MJ, Foley P, Stanford DG, Zagarella S, Reid C. Sentinel node biopsy: not the standard of care for melanoma. J Am Acad Dermatol 2009 May; 60(5): 872-875. PMID: 20227586

Rodrigues M, McCormack C, Yap LM, Prince HM, Roberts H, Williams R, Foley P. Successful treatment of lymphomatoid papulosis with photodynamic therapy. Australas J Dermatol 2009 May; 50(2): 129-132. PMID: 19397568

Ng J, Chong A, Foley P. Destructive management of skin cancers in organ transplant recipients. Cancer Treat Res 2009; 146: 447-460. PMID: 19415224

Yip L, Harrison S, Foley P. Infliximab rescue of efalizumab withdrawal flare and psoriasis-precipitated depression. Australas J Dermatol 2008 Nov; 49(3): 250-251. PMID: 18855796

Ross G, Foley P, Baker C. Actinic prurigo. Photodermatol Photoimmunol Photomed 2008 Oct; 24(5): 272-275. PMID: 18811871

Yip L, Harrison S, Foley P. From biologic to biologic to biologic: lessons to learn for erythrodermic and recalcitrant chronic plaque psoriasis. Australas J Dermatol 2008 Aug; 49(3): 152-155. PMID: 18638223

Ng J, Chong A, Foley P. The itchy scalp. Medicine Today 2008 Jul; 9(7): 42-50.

Williams B, Vanags D, Hall S, McCormack C, Foley P, Weiss J, Johnson B, Latz E, Feeney D. Efficacy and safety of chaperonin 10 in patients with moderate to severe plaque psoriasis: evidence of utility beyond a single indication. Arch Dermatol 2008 May; 144(5): 683-685. PMID: 18490603

Goh MS, McCormack C, Dinh HV, Welsh B, Foley P, Prince HM. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients. Br J Dermatol 2007 May; 156(5): 990-996. PMID: 17355229

Holmes C, Foley P, Freeman M, Chong AH. Solar keratosis: epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol [Solicited professional development program review] 2007 May; 48(2): 67-76. PMID: 17535191

Upjohn E, Foley P, Lane P, Magee J, Prince HM, McCormack C, Sinclair R. Long-term clearance of patch-stage mycosis fungoides with the 308-nm laser. Clin Exp Dermatol 2007 Mar; 32(2): 168-171. PMID: 17137475

Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA, International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus.  International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007 Jan; 56(1): 125-143. PMID: 17190630

Chia AL, Shumack S, Foley P. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005 Jul; 183(1): 52-53, author reply 53-54. PMID: 16180268

Foley P. Clinical efficacy of methyl aminolevulinate photodynamic therapy in basal cell carcinoma and solar keratosis. Australas J Dermatol 2005 Feb; 46: S8-10, discussion S23-S25. PMID: 15859301

Foley P. Practical aspects of methyl aminolevulinate photodynamic therapy. Australas J Dermatol 2005 Feb; 46: S12-S13; discussion S23-S25. PMID: 15859303

Foley P. Methyl aminolevulinate photodynamic therapy in practice: treatment protocol. Australas J Dermatol 2005 Feb; 46: S14; discussion S23-S25. PMID: 15859304

Foley P, Morton C, Rosen R, Vinciullo C. Photodynamic therapy: Practical aspects and questions. Question and answer panel. Australas J Dermatol 2005; 46: -25. PMIDs: 15859301, 15859303, 15859304

Tan B, Sinclair R, Foley P. Photodynamic therapy for subungual Bowen’s disease. Australas J Dermatol 2004 Aug; 45(3): 172-174. PMID: 15250896

Yap LM, Foley PA, Baker CS. Common causes and approach to management of photosensitivity. Modern Medicine of South Africa 2004; 18-32.

Chong A, Foley P, Sinclair R, Marks R. Viewpoints in dermatology: second cite.  A review of recent journal highlights. Clin Exp Dermatol 2004 Jan; 29(1): 107-109.

Thai K, Fergin P, Freeman M, Vinciullo C, Francis D, Spelman L, Murrell D, Anderson C, Weightman W, Reid C, Watson A, Foley P. A prospective study of the use of cryotherapy for the treatment of actinic keratoses. Int J Dermatol 2004 Sep; 43(9): 687-692. PMID: 15357755

Tan B, Foley P. Guttate psoriasis following Ecstasy ingestion. Australas J Dermatol 2004 Aug; 45(3): 167-169. PMID: 15250894

Foley P, Freeman M, Siller G, Gebauer K, et al. A phase III randomised study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (NBCC). J Eur Acad Dermatol Venereol 2003; 17(Suppl 3): 231.

Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat 2003; 14(Suppl 3): 15-22. PMID: 14522637

Yap LM, Foley PA, Baker C. Common causes and management of photosensitivity. Medicine Today 2003 May; 4(5): 30-39.

Yap LM, Foley PA, Baker CS. Photosensitivity: Common causes and approach to management. Modern Medicine 2003; 4:30-41.

Yap LM, Foley P, Crouch R, Baker C. Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology clinic. Australas J Dermatol 2003 Nov; 44(4): 256-262. PMID: 14616491

Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, Thai KE, Murrell D, Weightman W, Anderson C, Reid C, Watson A, Foley P. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003 Jun; 14(2): 99-106. PMID: 12775317

Yap LM, Blum R, Foley P, McCormack C, Turner H, Seymour JF, Prince HM. A clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer (EORTC) and World Health Organization (WHO) classifications. Australas J Dermatol 2003 May; 44(2): 110-115. PMID: 12752183

Crouch RB, Foley PA, Baker CS. Analysis of patients with suspected photosensitivity referred for investigation to an Australian photodermatology clinic. J Am Acad Dermatol 2003 May; 48(5): 714-720. PMID: 12734500

Curnow P, Foley P, Baker C. Multiple squamous cell carcinomas complicating linear porokeratosis. Australas J Dermatol 2003 May; 44(2): 136-139. PMID: 12752189

Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-age children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol 2003 Mar; 139(3): 318-322. PMID: 12622623

Crouch RB, Foley PA, Ng JC, Baker CS. Thalidomide experience of a major Australian teaching hospital. Australas J Dermatol 2002 Nov; 43(4): 278-284. PMID: 12423435

Scarff C, Baker C, Hill P, Foley P. Late onset warfarin necrosis. Australas J Dermatol 2002 Aug; 43(3): 202-206. PMID: 12121399

Ng JC, Foley PA, Crouch RB, Baker CS. Changes of photosensitivity and action spectrum with time in solar urticaria.  Photodermatol Photoimmunol Photomed 2002 Aug; 18(4):191-195.  PMID: 12390674

Freeman S, Howard A, Foley P, Rosen R, Wood G, See JA, Gray S. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrheic dermatitis. Australas J Dermatol 2002 Aug; 43(3): 186-189. PMID: 12121395

Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol 2002 May; 43(2): 128-132. PMID: 11982570

Crouch RB, Foley PA, Baker CS. The results of photopatch testing 172 patients to sunscreening agents at the photobiology clinic, St Vincent’s Hospital, Melbourne. Australas J Dermatol 2002 Feb; 43(1): 74. PMID: 11869216

Marks R, Foley PA, Sinclair RD. Dermatology. Med J Aust 2002 Jan; 176(1): 10. PMID: 11840910

Ng JC, Foley PA, Crouch RB, Baker CS. A case of severe actinic prurigo successfully treated with thalidomide. Australas J Dermatol 2001 Aug; 42(3): 192-195. PMID: 11488714

Foley P, Zuo Y, Plunkett A, Marks R. The frequency of common skin conditions in preschool-age children in Australia: atopic dermatitis. Arch Dermatol 2001 Mar; 137(3): 293-300. PMID: 11255327

Yap LM, Foley PA, Crouch RB, Baker CS. Drug-induced solar urticaria due to tetracycline. Australas J Dermatol 2000 Aug; 41(3): 181-184. PMID: 10954992

Foley PA. Recent advances: Dermatology. BMJ 2000 Mar; 320(7238): 850-853. PMID: 10731184

Foley P. Parathyroid hormone-related protein and skin cancer. Australas J Dermatol 1997 Jun; 38 (Suppl): S13-S19. PMID: 10994465

Foley P, Mason G. Keratotic basal cell carcinoma of the upper eyelid. Australas J Dermatol 1995 May; 36(2): 95-96. PMID: 7646397

Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol 1995 Apr; 131(4): 415-421. PMID: 7726582

Foley PA, Marks R, Dorevitch AP. Lentigo maligna is more common on the driver's side. Arch Dermatol 1993 Sep; 129(9): 1211-1212. PMID: 8363415

Foley P, Nixon R, Marks R, Frowen K, Thompson S. The frequency of reactions to sunscreens: results of a longitudinal population-based study on the regular use of sunscreens in Australia. Br J Dermatol 1993 May; 128(5): 512-518. PMID: 8504041

Marks R, Jolley D, Lectsas S, Foley P. The role of childhood exposure to sunlight in the development of solar keratoses and non-melanocytic skin cancer. Med J Aust 1990 Jan; 152(2): 62-66. PMID: 2296232

Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J 1988; 296: 13-17. PMID: 3122913

Marks R, Foley P, Goodman G, Hage BH, Selwood TS. Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 1986 Dec; 115(6): 649-655. PMID: 3801305

Foley P, Lanzer D, Marks R. Are solar keratoses more common on the driver's side? Br Med J 1986; 293: 18. PMID: 3089388

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login